TMCnet News
Global Tamoxifen Market 2017-2025 - Growth Trends, Key Players, Competitive Strategies - Research and MarketsThe "Global Tamoxifen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025" report has been added to Research and Markets' offering. The tamoxifen market was valued at USD 676.6 Mn in 2017, and is expected to reach USD 683.6 Mn by 2025, expanding at a CAGR of 0.07% from 2017 - 2025. This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured rimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market. The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Tamoxifen: Market Dynamics and Outlook Chapter 4 Global Tamoxifen Market, Pipeline Analysis Chapter 5 Global Tamoxifen Market, by Geography Chapter 6 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/z7ktf9/global_tamoxifen
View source version on businesswire.com: http://www.businesswire.com/news/home/20170927006140/en/ |
